Place of birth and outcomes associated with large volume transfusion: an observational study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
13 Sep 2021
Historique:
received: 19 05 2021
accepted: 29 08 2021
entrez: 14 9 2021
pubmed: 15 9 2021
medline: 19 11 2021
Statut: epublish

Résumé

Guidelines recommend that women at high risk of postpartum haemorrhage deliver at facilities able to handle heavy bleeding. However postpartum haemorrhage is often unexpected. This study aims to compare outcomes and health service use related to transfusion of ≥4 units of red blood cells between women delivering in tertiary and lower level hospitals. The study population was women giving birth in public hospitals in New South Wales, Australia, between July 2006 and December 2010. Data were obtained from linked hospital, birth and blood bank databases. The exposure of interest was transfusion of four or more units of red cells during admission for delivery. Outcomes included maternal morbidity, length of stay, neonatal morbidity and need for other blood products or transfer to higher care. Multivariable regression models were developed to predict need of transfusion of ≥4 units of red cells using variables known early in pregnancy and those known by the birth admission. Data were available for 231,603 births, of which 4309 involved a blood transfusion, with 1011 (0.4%) receiving 4 or more units. Women giving birth in lower level and/or smaller hospitals were more likely to receive ≥4 units of red cells. Women receiving ≥4 units in tertiary settings were more likely to receive other blood products and have longer hospital stays, but morbidity, readmission and hysterectomy rates were similar. Although 46% of women had no identifiable risk factors early in pregnancy, 20% of transfusions of ≥4 units occurred within this group. By the birth admission 70% of women had at least one risk factor for requiring ≥4 units of red cells. Overall outcomes for women receiving ≥4 units of red cells were comparable between tertiary and non-tertiary facilities. This is important given the inability of known risk factors to predict many instances of postpartum haemorrhage.

Sections du résumé

BACKGROUND BACKGROUND
Guidelines recommend that women at high risk of postpartum haemorrhage deliver at facilities able to handle heavy bleeding. However postpartum haemorrhage is often unexpected. This study aims to compare outcomes and health service use related to transfusion of ≥4 units of red blood cells between women delivering in tertiary and lower level hospitals.
METHODS METHODS
The study population was women giving birth in public hospitals in New South Wales, Australia, between July 2006 and December 2010. Data were obtained from linked hospital, birth and blood bank databases. The exposure of interest was transfusion of four or more units of red cells during admission for delivery. Outcomes included maternal morbidity, length of stay, neonatal morbidity and need for other blood products or transfer to higher care. Multivariable regression models were developed to predict need of transfusion of ≥4 units of red cells using variables known early in pregnancy and those known by the birth admission.
RESULTS RESULTS
Data were available for 231,603 births, of which 4309 involved a blood transfusion, with 1011 (0.4%) receiving 4 or more units. Women giving birth in lower level and/or smaller hospitals were more likely to receive ≥4 units of red cells. Women receiving ≥4 units in tertiary settings were more likely to receive other blood products and have longer hospital stays, but morbidity, readmission and hysterectomy rates were similar. Although 46% of women had no identifiable risk factors early in pregnancy, 20% of transfusions of ≥4 units occurred within this group. By the birth admission 70% of women had at least one risk factor for requiring ≥4 units of red cells.
CONCLUSIONS CONCLUSIONS
Overall outcomes for women receiving ≥4 units of red cells were comparable between tertiary and non-tertiary facilities. This is important given the inability of known risk factors to predict many instances of postpartum haemorrhage.

Identifiants

pubmed: 34517834
doi: 10.1186/s12884-021-04091-y
pii: 10.1186/s12884-021-04091-y
pmc: PMC8439088
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

620

Informations de copyright

© 2021. The Author(s).

Références

Am J Obstet Gynecol. 2015 Jul;213(1):76.e1-76.e10
pubmed: 25731692
Blood Transfus. 2019 Mar;17(2):112-136
pubmed: 30865585
J Matern Fetal Neonatal Med. 2014 Nov;27(16):1661-7
pubmed: 24313457
PLoS One. 2018 Dec 14;13(12):e0208417
pubmed: 30551126
Acta Obstet Gynecol Scand. 2019 Jun;98(6):795-804
pubmed: 30667050
Int J Popul Data Sci. 2020 Aug 12;5(1):1337
pubmed: 33644407
BMC Pregnancy Childbirth. 2011 Nov 28;11:97
pubmed: 22123123
J Matern Fetal Neonatal Med. 2018 Apr;31(8):1025-1034
pubmed: 28367647
J Obstet Gynaecol Res. 2015 Feb;41(2):199-206
pubmed: 25303234
Transfusion. 2016 Jul;56(7):1716-22
pubmed: 27060573
Curr Opin Anaesthesiol. 2014 Jun;27(3):275-81
pubmed: 24739249
BJOG. 2016 Dec;123(13):2164-2170
pubmed: 26694742
Am J Obstet Gynecol. 2016 Dec;215(6):795.e1-795.e14
pubmed: 27457112
Transfusion. 2014 Jul;54(7):1756-68
pubmed: 24617726
Acta Obstet Gynecol Scand. 2014 Apr;93(4):399-407
pubmed: 24575790
J Gynecol Obstet Hum Reprod. 2017 May;46(5):455-460
pubmed: 28934089
BJOG. 2019 Dec;126(13):1577-1586
pubmed: 31483935
BJOG. 2017 Apr;124(5):e106-e149
pubmed: 27981719
Obstet Gynecol. 2019 Sep;134(3):545-552
pubmed: 31403590
Int J Nurs Stud. 2018 Mar;79:114-121
pubmed: 29223625
Med Care. 2008 Aug;46(8):786-94
pubmed: 18665058
Am J Obstet Gynecol. 2013 Nov;209(5):449.e1-7
pubmed: 23871950
Obstet Gynecol. 2017 Oct;130(4):e168-e186
pubmed: 28937571
Obstet Gynecol. 2015 Jul;126(1):155-62
pubmed: 26241269

Auteurs

Jillian Patterson (J)

The University of Sydney Northern Clinical School, Women and Babies Research, St Leonards, New South Wales, Australia. jillian.patterson@sydney.edu.au.
Northern Sydney Local Health District, Kolling Institute, St Leonards, New South Wales, Australia. jillian.patterson@sydney.edu.au.
Women and Babies Research, c/o University Department of O&G, Level 5, Douglas Building, Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia. jillian.patterson@sydney.edu.au.

Deborah Randall (D)

The University of Sydney Northern Clinical School, Women and Babies Research, St Leonards, New South Wales, Australia.
Northern Sydney Local Health District, Kolling Institute, St Leonards, New South Wales, Australia.
Women and Babies Research, c/o University Department of O&G, Level 5, Douglas Building, Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia.

James Isbister (J)

The University of Sydney Northern Clinical School, St Leonards, New South Wales, Australia.

Michael Peek (M)

Australian National University Medical School, ANU, Garran, Australian Capital Territory, Australia.

Tanya Nippita (T)

The University of Sydney Northern Clinical School, Women and Babies Research, St Leonards, New South Wales, Australia.
Northern Sydney Local Health District, Kolling Institute, St Leonards, New South Wales, Australia.
Women and Babies Research, c/o University Department of O&G, Level 5, Douglas Building, Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia.
Department of Obstetrics and Gynaecology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.

Siranda Torvaldsen (S)

The University of Sydney Northern Clinical School, Women and Babies Research, St Leonards, New South Wales, Australia.
Northern Sydney Local Health District, Kolling Institute, St Leonards, New South Wales, Australia.
Women and Babies Research, c/o University Department of O&G, Level 5, Douglas Building, Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia.
School of Population Health, UNSW, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH